4.8 Article

Platform for Orthogonal N-Cysteine-Specific Protein Modification Enabled by Cyclopropenone Reagents

期刊

出版社

AMER CHEMICAL SOC
DOI: 10.1021/jacs.2c02185

关键词

-

资金

  1. Fundacao para a Ciencia e a Tecnologia, Portugal [CEECIND/00453/2018]
  2. Spanish Ministry of Science and Innovation (MCI)
  3. FEDER funds [RTI2018-099592-B-C21, RTI2018-099592-B- C22]
  4. Swiss National Science Foundation [P2BEP3_175253]
  5. Biotechnology and Biological Sciences Research Council (BBSRC) [BB/M01194]
  6. European Molecular Biology Organization (EMBO) [ALTF 1148-2020]
  7. AstraZeneca (AZ) [10045723]
  8. Carlsberg Foundation [CF18-0132, CF19-0060]
  9. Swiss National Science Foundation (SNF) [P2BEP3_175253] Funding Source: Swiss National Science Foundation (SNF)

向作者/读者索取更多资源

In this study, a new protein conjugation strategy using CPO-based reagents for selective modification of N-terminal cysteine residues was reported. The method achieved stable linkage under mild conditions and was compatible with common reducing agent DTT.
Protein conjugates are valuable tools for studying biological processes or producing therapeutics, such as antibody-drug conjugates. Despite the development of several protein conjugation strategies in recent years, the ability to modify one specific amino acid residue on a protein in the presence of other reactive side chains remains a challenge. We show that monosubstituted cyclopropenone (CPO) reagents react selectively with the 1,2-aminothiol groups of N-terminal cysteine residues to give a stable 1,4-thiazepan-5-one linkage under mild, biocompatible conditions. The CPO-based reagents, all accessible from a common activated ester CPO-pentafluorophenol (CPO-PFP), allow selective modification of N-terminal cysteine-containing peptides and proteins even in the presence of internal, solvent-exposed cysteine residues. This approach enabled the preparation of a dual protein conjugate of 2xcys-GFP, containing both internal and N-terminal cysteine residues, by first modifying the N-terminal residue with a CPO-based reagent followed by modification of the internal cysteine with a traditional cysteine-modifying reagent. CPO-based reagents enabled a copper-free click reaction between two proteins, producing a dimer of a de novo protein mimic of IL2 that binds to the beta-IL2 receptor with low nanomolar affinity. Importantly, the reagents are compatible with the common reducing agent dithiothreitol (DTT), a useful property for working with proteins prone to dimerization. Finally, quantum mechanical calculations uncover the origin of selectivity for CPO-based reagents for N-terminal cysteine residues. The ability to distinguish and specifically target N-terminal cysteine residues on proteins facilitates the construction of elaborate multilabeled bioconjugates with minimal protein engineering.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据